Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy.

Ekkelenkamp, Miquel B; Díez-Aguilar, María; Tunney, Michael M; Elborn, J Stuart; Fluit, Ad C; Cantón, Rafael

Ekkelenkamp, Miquel B; Díez-Aguilar, María; Tunney, Michael M; Elborn, J Stuart; Fluit, Ad C; Cantón, Rafael.

Afiliação

Ekkelenkamp MB; University Medical Center Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands.
Díez-Aguilar M; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Tunney MM; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain.
Elborn JS; Servicio de Microbiología y Parasitología, Hospital Universitario La Princesa, Madrid, Spain.
Fluit AC; Queen's University Belfast, Department of Pulmonology, Belfast, United Kingdom.
Cantón R; Queen's University Belfast, Department of Pulmonology, Belfast, United Kingdom.

Open Forum Infect Dis ; 9(4): ofac082, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35265731

Palavras-chave

antimicrobial resistance; bronchiectasis; chronic pulmonary infection; cystic fibrosis; inhaled antibiotics; susceptibility breakpoints

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google